American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

ACCP Emphasizes Importance of Board Certification to Key Stakeholders

In keeping with ACCP’s strategic plan, the College has released three new memos to key clinical pharmacy stakeholders drawing attention to the recently published ACCP Position Statement on Board Certification (see http://www.accp.com/docs/positions/positionStatements/BoardCertiPosStatmnt.pdf). The memos are addressed to three important stakeholder groups: (1) residency program directors, (2) deans of U.S. colleges and schools of pharmacy, and (3) academic pharmacy practice department chairs. Each memo, which can be found at http://www.accp.com/careers/specRecog.aspx, emphasizes elements of the position statement that pertain to practitioners who guide residency trainees in patient care roles, experiential program preceptors who oversee students during direct patient care experiences, or academic faculty who teach students pharmacotherapy-related subject matter. These communications, distributed in December and January either by U.S. mail or electronically, were accompanied by copies or links to both the ACCP Position Statement and the Board of Pharmacy Specialties (BPS) brochure, “…shouldn’t YOU get Board Certified?” available from BPS and online at http://www.accp.com/docs/careers/BPSbrochure.pdf.

ACCP members are encouraged to visit http://www.accp.com/careers/specRecog.aspx to review these communications and to engage in discussion of both the ACCP Position Statement and the memos with appropriate colleagues and/or supervisors.